ProxsysRx Receives Growth Equity Investment to Accelerate Expansion

Healthcare Solutions Company Targets New Markets

ProxsysRx, a healthcare solutions company, announced that it has received a significant growth equity investment from Atlanta-based Fulcrum Equity Partners with participation from members of the management team.

ProxsysRx announces significant growth equity investment from Fulcrum Equity Partners.

The funding will accelerate the company’s technological developments, expand the footprint of the organization to new markets around the United States, and provide additional infrastructure to support a larger company. The transaction was orchestrated by Nashville based investment banking firm Harpeth Capital. Fulcrum Partners Tom Greer and Jeff Muir lead the funding round; both have extensive backgrounds in growing healthcare services and IT businesses, and both will join the company’s Board of Directors.

Recommended AI News: Axcient Launches x360Recover Virtual Office

ProxsysRx provides hospital and health system partners with technology-driven value, revenue, and savings through innovative administrative systems and pharmacy programs that increase patient engagement to achieve positive health outcomes. The ProxsysRx executive team has more than one hundred years of combined healthcare industry experience.

“The Fulcrum Equity Partners investment will further amplify our positive growth trajectory and provide additional expertise which will help guide the direction of our expansion. We are excited about this new relationship and look forward to working closely with Fulcrum as we expand the company footprint and continue our trend of offering our health system partners new services that will benefit both their patients and the health system itself,” said ProxsysRx CEO George B. Salem. Salem notes that the majority of ProxsysRx partners are regional medical centers that stand to benefit from improved performance and patient care which are so vital in these challenging times.

Recommended AI News: Star Alliance Expands Strategic Partnership with TCS to Deliver Enhanced Customer Experiences

“We are excited about teaming with ProxsysRx in helping healthcare systems tackle challenging issues while improving health outcomes for patients. ProxsysRx benefits to partner healthcare systems are measurable and sustainable. Our investment in ProxsysRx will help the company accelerate its already impressive growth,” said Fulcrum partner Tom Greer who leads the investment team. Greer pointed out that ProxsysRx aligns perfectly with the Fulcrum Equity Partners investment model that supports rapidly growing companies that have proven entrepreneurial leadership and management in the healthcare and technology sectors.

Recommended AI News: Sophos Managed Threat Response (MTR) Named Best Managed Security Service